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SUMMARY
Brain abscess is uncommon in paediatric population, but of clinical importance because of
significant long-term morbidity and mortality. In this multicentre study, promoted by the Italian
Society for Paediatric Infectious Diseases, we retrospectively collected patients aged 0–18 years,
with a diagnosis of ‘brain abscess’. Seventy-nine children were included; the median age was 8·75
years. As predisposing factor, 44 children had preceding infections. The Gram-positive cocci were
mostly isolated (27 cases). Sixty (76%) children underwent a surgical intervention. Intravenous
antibiotic therapy was administered in all patients, then switched to oral treatment. Clinical
sequelae were recorded in 31 (39·2%) children. Twenty-one of them had a single sequela, of
which, the most represented, was epilepsy in nine of them. This study focus the attention on the
need to have standardized national guidelines or adequate recommendations on type and
duration of antibiotic treatment.
Key words: Anaerobic bacteria, antibiotics, bacterial infections, central nervous system infections,
emerging infections.
INTRODUCTION
Brain abscess (BA) is an infection that involves the
brain parenchyma starting as a localized area of cere-
britis, which evolves into a collection of encapsulated
purulent material [1]. It is uncommon in paediatric
population, but of clinical importance because of
significant long-term morbidity and mortality [2–4].
BAs in children were traditionally associated with
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congenital heart diseases and infections of the adja-
cent anatomic sites; the infection can spread haemato-
genously or by contiguity [2,3]. Probably due to
improvement in imaging and neurosurgical techniques
and the introduction of new antibiotic regimens, the
mortality has decreased, from 30% to 60% in the
late 1970s, to <10% in recent years [5].
The clinical onset of BA may be sneaky and it
depends on the age of the patient and on the size, loca-
tion and number of lesions [6]. The classic triad of
fever, headache and focal neurological signs was
seen in 9–28% of the paediatric cases [6,7].
The most often isolated pathogens of BAs belong to
Streptococcus spp., Staphylococcus spp. and Gram-
negative bacteria [8,9]. Among these, Streptococcus
spp. are markedly common in cases with paranasal
sinusitis, otitis and periorbital cellulitis, which are,
according to literature, more frequent predisposing
conditions for intracranial abscess in children [3].
Surgical treatment, associated with empirical broad-
spectrum antimicrobial therapy, is widely recom-
mended [1,2,5].
To our knowledge, there are only few surveys in the
European setting concerning the management of BAs
[2,5,6]. Other published studies generally analyze both
adults and children without providing a subset ana-
lysis for the paediatric population [9,10].
This is a retrospective, multicentre, observational
study, promoted by the Italian Society for Paediatric
Infectious Diseases (SITIP).
The aim of the survey was to analyze the clinical
presentation, risk factors, bacteriological isolates,
treatment and outcomes of children and adolescents
with a diagnosis of BA in Italy. Moreover, we have
reviewed and documented the temporal changes in
the predisposing factors and causative pathogens of
intracranial abscesses.
MATERIALS AND METHODS
All the institutions included in the network of the
SITIP received an invitation to participate in this
retrospective study; 15 paediatric centres agreed to
participate and reported at least one case of BA.
We have included children and adolescents aged 0–
18 years, admitted from 1 January 1998 to 31 May
2013 with a diagnosis of ‘BA’.
According to more recent definitions, we have con-
sidered BA a lesion located in the cerebrum, midbrain
or cerebellum, with characteristic features at com-
puted tomography (CT) or magnetic resonance
imaging (MRI) and/or evidence of pus during surgery
[6,7].
The World Health Organization International
Classification of Disease (ICD) version 10, code
G06.0 for intracranial abscess, was used. Patients
with subdural and epidural empyemas, fungal, para-
sitic, protozoa or tubercular abscesses were excluded.
Medical records have been carefully reviewed to
collect data on patient demographics (age and gen-
der), predisposing factors, signs and symptoms at
presentation, site and size of BAs, microbiological
and laboratory findings (peripheral white blood
count – WBC – and C reactive protein – CRP), radio-
logical imaging and treatment regimen. Data concern-
ing outcomes, sequelae (epilepsy, focal motor deficits,
visual impairment, hydrocephalous and speaking,
hearing or learning disorders) and infection recurrence
were evaluated.
To analyze the temporal changes in predisposing
factors and responsible microorganisms, we have split
the study period in two: 1998–2005 and 2006–2013.
Statistical analysis was performed using Ministat 2.1
and OpenEpi. The differences between groups were
analyzed using the t test or Mann-Whitney test for
continuous data, or χ2 test or the Fisher exact test
for categorical data, as appropriate. All tests were
two sided and the significance was set at P4 0·05.
RESULTS
Ninety-four potential cases were identified, but 15
were excluded on the basis of the exclusion criteria
(seven post-meningitis empyemas and eight fungal
abscesses). Therefore, 79 children were included in
the study (male-to-female ratio was 1·8); the median
age was 8·75 years (range IQR 2·46–12·33 years). It
might be thought that the majority of patients
(55·6%) are actually children aged <10 years. Males
were not significantly older than girls (median 9·4 vs.
4·4 years, P = 0·10).
Predisposing factors
The predisposing factors were identified in 68 (86%)
subjects: 44 (55·7%) had preceding infections (16 rhi-
nosinusitis – 14 frontal and two involving ethmoidal
sinus – seven acute otitis, seven acute mastoiditis, six
sepsis, three orbital cellulitis, three dental abscess,
one endocarditis and one parapharyngeal abscess),
seven (8·9%) underwent a previous neurosurgical pro-
cedures, six (7·6%) had a congenital heart disease, four
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(5%) had a head trauma, four (5%) were immunocom-
promised (two had a congenital form and two had an
acquired immunosuppression) and finally three (3·8%)
had brain malformations. No predisposing factors
were identified in 11 (14%) of subjects.
Eight (42%) of 19 cases reported in the first period
had a preceding infection, compared with 36 (60%) of
60 cases reported during the second period (P = 0·19);
whereas the congenital heart diseases were less fre-
quent in both periods: two (10%) cases and four
(6%) cases, respectively, in 1998–2005 and 2006–
2013 (P = 0·69).
Clinical features
In 70 (88·6%) children, signs and symptoms at admis-
sion have been documented (see Table 1). The median
duration of signs and symptoms before the diagnosis
of BA was 7 days (range IQR 2–13·5 days).
Because of the suspected infection, 36 (45·6%) chil-
dren had previously received an antibiotic therapy,
particularly β lactams (n= 23), for a mean duration
of 8·7 ± 7·3 days (range 2–37 days).
Laboratory findings
In 72 (91·1%) patients, laboratory data on admission
were available. The median WBC count was 14 210
cells/mm3 (range IQR 10 140–18 700 cells/mm3); in
56 (77·7%) children the WBC count was >10 000/
mm3; whereas three (4·1%) had leucopaenia with
<5000 cells/mm3. The CRP was increased (55 mg/l)
in 52 (72%) patients, with a median level of 10·1
mg/l (range IQR 3·5–18·4 mg/l).
Blood cultures were performed in 44 out of 79
(55·7%) children, but they were positive only in 10
of the 44 cases (positive rate = 22·7%). In these 10
positive blood cultures, the same microorganism has
been isolated also in brain pus.
The lumbar puncture was performed in 25 (31·6%)
children, in the initial suspicion of meningitis:
the mean cell count was 4792·2 ± 10 976·4/mm3, the
mean protein level was 212·8 ± 278·2/mm3 and the
glucose level was 38·9 ± 26·3 mg/dl. The cerebro-
spinal fluid culture was positive in six cases (positive
rate = 24%).
Radiological findings
Neuroimaging study was available in 76 patients: 69
(90·7%) of them had CT scan on admission; whereas,
in the other seven (9·3%), the MRI was the first cere-
bral imaging.
There were 58 (73·4%) single BAs and 21 (26·6%)
multiple. The location, for solitary lesions, is pre-
sented in Table 2. The mean abscess diameter was
2·7 ± 1·5 cm (range 0·25–5·7 cm).
Management
Sixty (76%) children underwent a surgical interven-
tion: 51/60 (85%) had a drainage of the lesion, 7/60
(11·7%) had a resection and 2/60 (3·3%) had other sur-
gical approach. The time between the onset of symp-
toms and surgery ranged from 0 to 22 days, for
those so treated.
Subjects who received surgical treatment were
mainly males (39 over 60 children, 65%) with a
median age of 8·9 years (IQR 2·4–12·2 years). The
mean length of hospital stay was 43·5 ± 23·6 days
(range 9–140 days). They received a previous anti-
biotic therapy in 25/60 cases (41·7%). A single BA
was more frequent in these subjects (47 over 60
cases, 78·3%) and the most usual location was the
frontal lobe (20/60 BAs, 33·3%), with a mean BA’s
diameter of 3 ± 1·6 cm (range 0·5–6 cm), which was
significantly greater than those who did not receive
surgical treatment (P= 0·0005, CI: confidence interval
95% 0·46–0·56). The mean length of antibiotic treat-
ment, in these subjects, was 57·8 ± 30·2 days (range
15–159 days). Twenty-four of them (40%) developed
a sequela. In surgical treated patients, we recorded
6/60 (10%) recurrence and 1/60 (1·6%) death.
Examining separately, those who underwent resec-
tion had single BA in 6/7 cases (85·7%), with a preva-
lent location in the frontal lobe (three cases over
seven, 42·8%). No recurrence occurred.
Similarly, those who received the drainage had fre-
quently a single lesion (40/51, 78·4%), located in the
frontal lobe (17/51 BAs, 33·3%). No correlations
were found between abscess location and surgical pro-
cedures (P = 0·68). Recurrence was recorded in six
cases (6/51, 11·8%).
Children who received only medical treatment were
12 males and seven females with a median age of 5·6
years (IQR 1·9–12 years). The mean duration of hos-
pital stay, for this group, was 50·4 ± 19·8 days (range
17–98 days). Eleven of them (11/19, 57·9%) had
received a previous oral antibiotic therapy. The BA
was single in 11 cases over 19 (57·9%), and the prevalent
location was the frontal lobe (4/19 BAs, 21%). The
mean BA diameter, in this group, was 1·7 ± 0·9 cm
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(range 0·3–3 cm). The mean duration of antibiotic
therapy was 65·3 ± 21·2 days (range 30–119 days),
not significantly longer than those who underwent sur-
gical treatment (P = 0·22). Eight children (8/19,
42·1%) developed a sequela; nor recurrences neither
deaths were recorded in this group.
Intravenous (i.v.) antibiotic therapy was adminis-
tered in all patients, then switched to oral treatment,
based on inflammatory index decrease and improve-
ment of patient’s clinical condition.
Only two (2·5%) children received a single anti-
biotic therapy; whereas the majority of the population
received an association of antibiotics, as empiric
choice. The most frequent antibiotic used was a
third generation cephalosporin (ceftriaxone or cefo-
taxime) alone in one case, or associated only with
metronidazole in six cases or with metronidazole
plus another drug (such as vancomycin or teicoplanin)
in nine subjects. In 18 patients, the empiric antibiotic
regimen included a third generation cephalosporin in
association with antibiotics other than metronidazole.
Further antibiotics were used as initial treatment, in
29 (36·7%) cases.
Amoxicillin/clavulanate was primarily used, in the
oral treatment.
Antibiotic therapy was changed, according to
microbiological results, as appropriate.
The mean length of overall antibiotic therapy was
59·5 ± 28·4 days (range 15–159 days); whereas the
mean i.v. administration was 42·8 ± 18·3 days (range
5–120 days).
Microbiology
The pathogens responsible of the BA, isolated from
blood, pus cultures or both, were documented in 43
(54·4%) cases. The microorganisms isolated are
shown in Table 3.
Analyzing separately children in whom BA was a
consequence of spread of a contiguous infection, the
most frequent responsible pathogens were
Streptococcus spp. (11 cases) of which five were
Streptococcus intermedius, isolated from pus. Three of
them had a frontal localization of BA; whereas the
other were one in temporal lobe and one in the occipi-
tal lobe. In four cases Staphylococcus spp. was isolated;
four Enterobacteriaceae were isolated and two
Anaerobes also. Lastly, 16 pus cultures were negative.
The Streptococcus spp. increased significantly
through the study period, passing from three cases
(15·7%) to 14 cases (23·3%); whereas a reduction of
Gram-negative bacteria was recorded.
Outcomes
Clinical sequelae were recorded in 31(39·2%) children.
Twenty-one of them had a single sequela: nine (42·9%)
epilepsy, five (23·8%) focal motor deficits, three
(14·3%) visual impairment, three (14·3%) hydrocepha-
lous, one (4·7%) language disease. Ten (32·2%)
patients had multiple sequelae, of whom seven pre-
sented seizures associated to at least one other neuro-
logical sign (such as learning or behaviour disorders,
language, visual or hearing disturbances), one had
focal motor deficits and hearing diseases, one had
hydrocephalous and behaviour disorders and the last
Table 1. Signs and symptoms of brain abscess at
admission
No. of patients (%)
General signs and symptoms
Fever 53 (67)
Headache 48 (60·7)
Vomiting 31 (39·2)
Altered level of consciousness 28 (35·4)
Dizziness 5 (6·3)
Increasing head circumference 2 (2·5)
Bulging fontanel 1 (1·2)
Neurological signs and symptoms
Generalized tonic–clonic seizures 17 (21·5)
Hemiplegia 9 (11·3)
Expressive dysphasia 9 (11·3)
Abnormal gait 9 (11·3)
Partial seizures 8 (10·1)
Cranial nerve palsy 3 (3·7)
Status epilepticus 2 (2·5)
Hypotonia 1 (1·2)
Visual signs and symptoms
Photophobia 8 (10·1)
Papillo-oedema 2 (2·5)
Ptosis 2 (2·5)
Decreased visual acuity 1 (1·2)
Diplopia 1 (1·2)
Table 2. Location of solitary brain abscesses
Site No. of patients (%)
Frontal lobe 25 (43·1)
Parietal lobe 13 (22·4)
Temporal lobe 9 (15·5)
Occipital lobe 5 (8·7)
Cerebellum 4 (6·9)
Basal ganglia and thalamus 2 (3·4)
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patient had focal motor deficits with learning
disorders.
Clinical follow-up ranged from 1 to 109 months
(median 6·4 months). In six (7·5%) cases, a recurrent
disease was reported. The mean duration of antibiotic
therapy in children with a recurrent disease was not
significantly different than those who have not (64·1
vs. 59·1 days, respectively, P= 0·78). The mortality
rate was 1·2% (one case). The death occurred after 2
months from the diagnosis.
At univariate analysis (shown on Table 4), the only
two significant risk factors to develop clinical sequelae
were the presence of neurological signs at admission
(P = 0·003) and the duration of antibiotic treatment
(P = 0·03).
DISCUSSION
This is the first multicentre Italian paediatric study
which analyzes BA’s incidence in our Country, delin-
eating microbiological and clinical aspects and provid-
ing our experience on the management of this disease.
The gender and age distribution is similar to those
reported by other recent studies [3,6], highlighting a
male prevalence. In our study, the median age was
8·75 years, corresponding to the sinusitis, otitis
media, mastoiditis and orbital cellulitis peak of inci-
dence [11]. The number of BAs markedly increased
during the two study periods (from 19 to 60 cases)
probably provoked by the simultaneous increase, in
Italy, of otitis media and mastoiditis’ incidence
[12,13]. In fact, the main predisposing factor, recorded
in this survey, was a contiguous focus of infection,
such as sinusitis, acute otitis or mastoiditis (16, 7
and 7 patients, respectively). Differently from other
reports, the fungal BAs were excluded, so the
immunocompromised population is scarce in this
series [14].
In contrast to what reported by Manzar et al., we
did not find congenital heart disease being a consistent
predisposing condition for BA (six cases, 7·6%),
maybe because congenital heart diseases, in Italy,
were early corrected [15]. In our analysis, immunosup-
pression and congenital heart diseases were not related
to a major risk to develop a long-term sequela: this is
probably due to a small sample size.
Clinical manifestations depend on the stage of the
disease, virulence of the pathogen involved, immuno-
logical status of the patient, number, location of BA
and presence or absence of associated meningitis or
ventriculitis [5]. Most often the clinical symptoms
are related to increase of intracranial pressure and
are secondary to the focal effects of the mass and
included non-specific manifestations, such as head-
ache, nausea and vomiting [5]. In our series, as in
other recent reports, the commonest symptoms at
admission were non-specific, such as fever, headache
and vomiting [3,6,7]. Instead some other authors
found neurological signs as the major feature at the
presentation, but, differently from our study, they
have included headache in neurological symptoms
and not in general ones [7,16].
The presentation with non-specific signs and symp-
toms could explain the delay in the diagnosis of BA; in
our study, the median duration of symptoms before
the diagnosis was 7 days. This is similar to those
recorded in other European countries [2,3] and prob-
ably reflects a good clinical practice and an increasing
diagnostic sensitivity towards this disease. Among
neurological signs and symptoms seizures were the
commonest, in line with Cole in her recent report [2].
Furthermore, in this survey, the presentation of a
neurological sign or symptom on admission was stat-
istically related to an increased risk to develop seque-
lae (0 = 0·003). In our study, the more frequent
Table 3. Type of pathogens isolated
Type of microorganism No. of cases
Gram-positive cocci
Viridans group Streptococci 13a
Staphylococcus aureus 4b
Coagulase negative Staphylococci 4c
Streptococcus pneumoniae 3d
β-Haemolytic Streptococci group B 2
Enterococcus faecalis 1e
Enterobacteriaceae
Enterobacter cloacae 2f
Proteus mirabilis 2
Escherichia coli 1g
Klebsiella oxytoca 1
Citrobacter koseri 1h
Salmonella typhi 1i
Anaerobes 4
Polimicrobial 4
Negative 22
a One isolated from blood.
b One isolated from cerebrospinal fluid (CSF).
c One isolated from blood.
d Two isolated from CSF and 1 from blood.
e Isolated from CSF.
f Two isolated from blood.
g Isolated from blood and 1 from CSF.
h Isolated from blood.
i Isolated from blood.
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neurological manifestations were generalized tonic–
clonic seizures, partial seizures and status epilepticus,
often prolonged and severe at presentation, so long-
term sequelae could be more possible in these patients.
Currently, lumbar puncture is not recommended
because it can result in transforaminal or transten-
torial herniation and consequent death [10,17].
Moreover, the microbiological analysis of cerebral
fluid could not aid in the diagnosis of an unruptured
BA. In our series, this procedure has been performed
only in 31·6% of children, because of high suspicion of
meningitis, and in all cases, there were no signs of
increased intracranial pressure. The blood culture
was positive only in 10 cases, underlying the need to
use it during febrile episode, in order to document
bacteraemia, thus directing the microbiological
diagnosis.
The neuroimaging techniques, such as CT or MRI,
allow to confirm BA diagnosis and to determine the
location and the number of lesions [1]. CT imaging
has proved to have many advantages: first, it can be
already performed in the emergency department,
allowing an immediate diagnosis. Second, it is useful
in determining the location, size, mass effects, number
of BA, together with providing information regarding
the cause of BA, exploring also paranasal sinuses and
mastoids [18,19]. Although MRI may be more
sensitive in differentiating an abscess from other cystic
lesions, the use of this technique is not recommended
routinely in an acutely ill patient [18]. In our analysis,
the vast majority of patients (90·7%) had CT scan on
admission; MRI has been used in very few cases
(seven, 9·3%) to diagnose BA.
As recently highlighted by other authors, even in
our survey, the frontal lobe was the prevalent location
[6,7]: this is often provoked by the spread of a contigu-
ous infection, especially from paranasal sinus, as
shown in our analysis.
Gram-positive cocci, particularly viridans group
streptococci, were the predominant pathogens iso-
lated; consistent with other European series [2,3,10].
We have recorded a decline of Streptococcus pneumo-
niae in the pathogenesis of BAs, probably due to
implementation of vaccine coverage of Italian paedi-
atric population, with an estimated mean coverage
in 2015 of 88·73% [20]. In 22 cases, the pus culture
was sterile: this could be explained by the previous
administration of oral antibiotic before the diagnosis
of BA, frequently happened in our setting (45·6% of
children) and also by the difficulty to obtain adequate
sample for microbiological analysis.
Treatment of BAs is still controversial. Gelabert-
Gonzales et al. and Shachor-Meyouhas et al. had
treated all their patients with a surgical approach
Table 4. Results of univariate analysis for sequelae
Risk factor
Patients with sequelae
(n= 31)
Patients without sequelae
(n= 48) OR (95% CI) P
Age4 5 years 13 (42) 16 (33·3) 1·4 (0·5–3·6) 0·59
Immunodeficiency 0 (0) 4 (8) – 0·26
Congenital heart diseases 2 (6) 4 (8) 0·7 (0·1–4·4) 0·89
Fever 22 (71) 31 (64·5%) 1·3 (0·5–3·5) 0·73
Neurological signs at admission 18 (58) 11 (23) 4·6 (1·7–12·4) 0·003
Mean diameter, cm 2·88 ± 1·73 2·68 ± 1·44 – 0·57
Location
Frontal lobe 7 (22·5) 17 (35·4) 0·3 (0·1–1) 0·09
Parietal lobe 7 (22·5) 5 (10) 2·1 (0·6–7·8) 0·32
Occipital lobe 1 (3) 4 (8) 0·3 (0–2·8) 0·37
Temporal lobe 5 (16) 3 (6) 2·4 (0·5–11·5) 0·27
Cerebellum 3 (9·6) 1 (2) 4·3 (0·4–44) 0·30
Other 1 (3) 1 (2) 1·3 (0–22) 0·99
Pathogen
Gram-positive cocci 7 (22·5) 21 (43) 0·4 (0·1–1·5) 0·16
Enterobacteriaceae 5 (16) 3 (6) 5 (0·9–25·2) 0·08
Anaerobes 2 (6) 2 (4) 2·3 (0·3–18·5) 0·58
Antibiotic treatment only 7 (22·5) 12 (25) 0·9 (0·3–2·5) 0·99
Duration antibiotic treatment, days 67·8 ± 33·3 53·8 ± 23·3 – 0·03
Values represent numbers of patients with percentages in parentheses or means ± S.D., except where indicated otherwise.
Brain abscesses in children 2853
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0950268817001583
Downloaded from https://www.cambridge.org/core. UNI ROMA LA SAPIENZA, on 28 Nov 2017 at 16:53:18, subject to the Cambridge Core terms of use, available at
[5,7]. Other authors, such as Cole, suggested a medical
therapy alone only in selected cases [2]. In our series,
the major part of children (76%) underwent a surgical
intervention. Children with stable neurological status,
small BA’s diameter and multiple abscesses, received
only the medical treatment. Nowadays there are not
clear indications to choose the medical approach
alone instead of the surgical treatment. It is interesting
that in our survey those who underwent also the sur-
gical intervention were those who had a significant
greater BA. Unfortunately, no correlations between
site of BA and type of surgery emerged from our
material, probably due to the high prevalence of
frontal location in the whole study population,
which might lead to a selection bias.
The choice, route and duration of empirical anti-
biotic regimen were extremely variable in our survey,
reflecting the lack of consensus guideline. As sug-
gested by other authors, an appropriate antimicrobial
treatment should contemplate at least two agents: a
third generation cephalosporin (ceftriaxone or cefo-
taxime) with metronidazole may be used to cover
the most likely pathogens pending on specific organ-
ism identification [3–5, 21]. The boost with a carbape-
nem would potentially increase effective treatment
because of its good spreading in cerebral tissue and
its ability to counteract Gram-negative pathogens
[3]. In case of high suspicion of methicillin-resistant
Staphylococcus aureus infection, then vancomycin
should be used [3]. According to more recent recom-
mendations, the most frequent empiric antibiotic
used, in our study, was a third generation cephalo-
sporin (ceftriaxone or cefotaxime) alone or associated
only with metronidazole or with metronidazole plus
another drugs (such as vancomycin or teicoplanin).
Currently there are no national guidelines, in Italy,
for the therapy of BA in paediatric setting, so also the
duration of antimicrobial treatment, both i.v. and oral
routes, is not yet standardized. In our series, the mean
length of overall antibiotic therapy and the mean i.v.
administration were similar to what reported by
Felsenstein et al. and Gelabert-Gonzales et al. [3,5].
The duration of antibiotic treatment was significantly
longer in patients who developed a sequela (P =
0·032); this is because they were probably more severe
cases.
The mortality is markedly declined in the last dec-
ades: we have reported a mortality rate of 1·2%,
lower than the other European studies [2,3,10].
Clinical sequelae were recorded in 31 (39·2%) chil-
dren, of which epilepsy and focal motor deficits were
more frequent. In a small Spanish series Gelabert-
Gonzales et al. reported 4/28 children with motor
deficit or visual impairment, four with hydrocepha-
lous and 11 who needed an antiepileptic therapy [5].
Felsenstein et al. described an incidence of sequelae
similar to us: 21/118 patients with mild or moderate
deficit and 12 with severe deficit [3].
In our survey, the recurrence rate was 7·5%, which
is lower than in other studies [10]. The mean duration
of antibiotic therapy was not different for patients
with a recurrent disease; it is probably due to the
small sample size.
The strength of this survey is the large number of
Italian paediatric centres involved. Due to the retro-
spective nature of this study, some data were not avail-
able, especially concerning the follow-up of those
diagnosed in the first period (1998–2000).
In conclusion, despite the estimated incidence of
BA in developed countries is relatively low (0·9 per
100 000 person-years), clinicians should consider it
when evaluating a child with seizures, headache or
other neurologic symptoms, mainly if he had some
predisposing factors [22].
The extreme variability in the antibiotic therapy,
underlined by our material, focus the attention on
the need to have standardized national guidelines or
adequate recommendations on type and duration of
antibiotic treatment.
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